CN(C(=O)c1ccc(NC(=O)Cc2ccc(NC(=O)C3CCCN(C(=O)c4ccccc4)C3)cc2)cc1)C1CC1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?